Spots Global Cancer Trial Database for major depressive disorder
Every month we try and update this database with for major depressive disorder cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients | NCT03674138 | Depression Anxiety Generalized Anx... Depressive Diso... Major Depressiv... Cancer | DNA-guided choi... Clinical manage... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Stellate Ganglion Block for Major Depressive Disorder. | NCT04727229 | Treatment Resis... Major Depressiv... | Bupivacaine Hyd... Normal Saline | 18 Years - 65 Years | Unity Health Toronto | |
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With Cancer | NCT05947383 | Cancer Major Depressiv... | Psilocybin Placebo | 18 Years - | Sunstone Medical | |
Wellbutrin XL, Major Depressive Disorder and Breast Cancer | NCT00234195 | Breast Cancer Major Depressiv... | bupropion exten... | 18 Years - | Thomas Jefferson University | |
Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients | NCT03674138 | Depression Anxiety Generalized Anx... Depressive Diso... Major Depressiv... Cancer | DNA-guided choi... Clinical manage... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Stellate Ganglion Block for Major Depressive Disorder. | NCT04727229 | Treatment Resis... Major Depressiv... | Bupivacaine Hyd... Normal Saline | 18 Years - 65 Years | Unity Health Toronto | |
Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients | NCT03674138 | Depression Anxiety Generalized Anx... Depressive Diso... Major Depressiv... Cancer | DNA-guided choi... Clinical manage... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
The Internet Therapy for Depression Trial | NCT04009135 | Chronic Pain Major Depressiv... | internet delive... online delivere... Attention Contr... | 18 Years - 80 Years | Memorial University of Newfoundland | |
A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients | NCT03833206 | Major Depressiv... | PDC-1421 Capsul... | 21 Years - 85 Years | BioLite, Inc. | |
Ketamine or Placebo in Patients With Major Depression and Advanced Cancer | NCT04471818 | Major Depressiv... Advanced Cancer | Ketamine Placebo | 18 Years - 65 Years | Instituto Nacional de Cancerologia de Mexico | |
Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer | NCT01725048 | Major Depressiv... Neoplasms | Mirtazapine Citalopram | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
Vortioxetine for Cancer Patients With Depression: An Observational Study | NCT04253678 | Major Depressiv... Cancer | Vortioxetine | 18 Years - | University of Malaya | |
Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer | NCT04973930 | Major Depressiv... Breast Cancer Venlafaxine | Interpersonal P... Venlafaxine HCl... | 18 Years - 80 Years | New York State Psychiatric Institute | |
Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer | NCT04973930 | Major Depressiv... Breast Cancer Venlafaxine | Interpersonal P... Venlafaxine HCl... | 18 Years - 80 Years | New York State Psychiatric Institute | |
Wellbutrin XL, Major Depressive Disorder and Breast Cancer | NCT00234195 | Breast Cancer Major Depressiv... | bupropion exten... | 18 Years - | Thomas Jefferson University |